Response to “Comment on: ‘When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council’”

Eric L. Simpson; Nick J. Reynolds; Carsten Flohr; Amy S. Paller; Jonathan I. Silverberg; Michel J. Cork; Emma Guttman-Yassky; Alan D. Irvine

doi:10.1016/j.jaad.2018.03.048

Response to “Comment on: ‘When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council’”

Eric L. Simpson, Nick J. Reynolds, Carsten Flohr, Amy S. Paller, Jonathan I. Silverberg, Michel J. Cork, Emma Guttman-Yassky, Alan D. Irvine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	e25-e26
Journal	Journal of the American Academy of Dermatology
Volume	79
Issue number	2
DOIs	https://doi.org/10.1016/j.jaad.2018.03.048
State	Published - Aug 2018

Access to Document

10.1016/j.jaad.2018.03.048

Cite this

Simpson, E. L., Reynolds, N. J., Flohr, C., Paller, A. S., Silverberg, J. I., Cork, M. J., Guttman-Yassky, E., & Irvine, A. D. (2018). Response to “Comment on: ‘When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council’”. Journal of the American Academy of Dermatology, 79(2), e25-e26. https://doi.org/10.1016/j.jaad.2018.03.048

@article{289a0e6b42114459b0b1819950e323e1,

title = "Response to “Comment on: {\textquoteleft}When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council{\textquoteright}”",

author = "Simpson, {Eric L.} and Reynolds, {Nick J.} and Carsten Flohr and Paller, {Amy S.} and Silverberg, {Jonathan I.} and Cork, {Michel J.} and Emma Guttman-Yassky and Irvine, {Alan D.}",

note = "Funding Information: Funding sources: Corporate sponsorship was provided to the International Eczema Council by Abbvie, Amgen, Celgene, Chugai, Galderma, Glaxo-SmithKline/Stiefel, the Leo Foundation, Leo Pharma, Lilly, MedImmune/Astrazeneca, Pfizer, Sanofi, Genzyme and Regeneron Pharmaceuticals, and Valeant. The cost of publication was covered by the International Eczema Council. ",

year = "2018",

month = aug,

doi = "10.1016/j.jaad.2018.03.048",

language = "English",

volume = "79",

pages = "e25--e26",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "2",

}

Simpson, EL, Reynolds, NJ, Flohr, C, Paller, AS, Silverberg, JI, Cork, MJ, Guttman-Yassky, E & Irvine, AD 2018, 'Response to “Comment on: ‘When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council’”', Journal of the American Academy of Dermatology, vol. 79, no. 2, pp. e25-e26. https://doi.org/10.1016/j.jaad.2018.03.048

Response to “Comment on: ‘When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council’”. / Simpson, Eric L.; Reynolds, Nick J.; Flohr, Carsten et al.
In: Journal of the American Academy of Dermatology, Vol. 79, No. 2, 08.2018, p. e25-e26.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Response to “Comment on

T2 - ‘When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council’”

AU - Simpson, Eric L.

AU - Reynolds, Nick J.

AU - Flohr, Carsten

AU - Paller, Amy S.

AU - Silverberg, Jonathan I.

AU - Cork, Michel J.

AU - Guttman-Yassky, Emma

AU - Irvine, Alan D.

N1 - Funding Information: Funding sources: Corporate sponsorship was provided to the International Eczema Council by Abbvie, Amgen, Celgene, Chugai, Galderma, Glaxo-SmithKline/Stiefel, the Leo Foundation, Leo Pharma, Lilly, MedImmune/Astrazeneca, Pfizer, Sanofi, Genzyme and Regeneron Pharmaceuticals, and Valeant. The cost of publication was covered by the International Eczema Council.

PY - 2018/8

Y1 - 2018/8

UR - http://www.scopus.com/inward/record.url?scp=85049805880&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.03.048

DO - 10.1016/j.jaad.2018.03.048

M3 - Letter

C2 - 30012284

AN - SCOPUS:85049805880

SN - 0190-9622

VL - 79

SP - e25-e26

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 2

ER -